Cathy E Petty, MD | |
907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 | |
(865) 983-7211 | |
(865) 450-9374 |
Full Name | Cathy E Petty |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Location | 907 E Lamar Alexander Pkwy, Maryville, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003897141 | NPI | - | NPPES |
3027925 | Medicaid | TN | |
3028647 | Other | TN | BLUE CROSS BLUE SHIELD TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 17827 (Tennessee) | Primary |
Entity Name | Maryville Anesthesiologists Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336199645 PECOS PAC ID: 0345257606 Enrollment ID: O20060310000282 |
News Archive
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.
Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.
Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Cathy E Petty, MD Po Box 24776, Chattanooga, TN 37422-4776 Ph: (877) 288-1799 | Cathy E Petty, MD 907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 Ph: (865) 983-7211 |
News Archive
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.
Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.
Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates in the brains of people with Alzheimer's disease.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that on Friday, May 29, 2010, the American Society for Apheresis will present Fenwal biomedical engineer Katherine Radwanski with the prestigious Junior Investigator Award for her research on photopheresis.
Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer.
› Verified 8 days ago
Immaculate Thomason, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5760 Fax: 865-977-4788 | |
Cheryl E Coleman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-7211 Fax: 865-450-9374 | |
Jerry M Gilley, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-7211 Fax: 865-450-9374 | |
Anthony Ragsdale, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-7211 Fax: 865-450-9374 | |
Denise Liyana Charlton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-977-5760 Fax: 865-977-4788 | |
Jon L Cheek, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-983-7211 |